Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-929-7 | CAS number: 25383-99-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritation in vitro (OECD 439, EpiDerm): not irritating
Eye irritation in vitro (OECD 437, BCOP): not irritating
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 Sept - 11 Oct 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- adopted in 2019
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- adopted in 2012
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- other: EpiDermTM (EPI-200)
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™ (EPI-200-SIT) (MatTek Corporation, 82105 Bratislava, Slovakia)
- Tissue batch number(s): 30830
- Date of initiation of testing: 12 Sept 2019
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 35 min at 37 ± 1.5 °C and 5 ± 0.5% CO2 in Dulbecco's Minimum Essential Medium (DMEM) followed by 25 min in a sterile bench at room temperature
- Temperature of post-treatment incubation: approx. 42 h at 37 ± 1.5 °C and 5 ± 0.5% CO2 in DMEM
REMOVAL OF TEST MATERIAL AND CONTROLS
- Volume and number of washing steps: rinsed with Phosphate Buffered Saline (PBS) several times
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 300 μl/well
- Incubation time: 3 h ± 5 min
- Spectrophotometer: microplate reader (Versamax® Molecular Devices, Software SoftMax Pro Enterprise version 4.7.1)
- Wavelength: 570 nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: The quality of the EpiDerm™ tissue was assessed by an MTT cell viability test. The determined OD (540 - 570 nm) was 1.946 ± 0.146 (acceptance criteria: 1.0 - 3.0).
- Barrier function: The barrier function was assessed by determination of the exposure time required to reduce tissue viability by 50% (ET-50) upon application of 100 µL of 1% Triton X-100. The ET-50 value was determined to be 5.05 h (acceptance criteria: 4.77-8.72 h).
- Contamination: The cells used to produce the EpiDerm™ tissue were screened for the presence of viruses, bacteria, yeast and other fungi. No contamination was detected.
NUMBER OF REPLICATE TISSUES: 3
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
Since the test substance did not directly reduce the MTT solution, an additional functional check was not performed.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: single experiment
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- The test substance is considered to be irritant or corrosive to skin if the viability after 1 h exposure is ≤ 50%.
- The test substance is considered to be non-irritant to skin if the viability after 1 h exposure is > 50%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 25 mg (corresponding to 39.7 mg/cm2) + 25 µL DPBS - Duration of treatment / exposure:
- 35 min at 37 °C and 25 min at RT
- Duration of post-treatment incubation (if applicable):
- Approx. 42 h
- Number of replicates:
- Triplicates for each treatment and control group
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- mean value of 3 tissues
- Run / experiment:
- 1 h exposure
- Value:
- 100.16
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Direct-MTT reduction: Since the test substance did not directly reduce MTT, an additional test with freeze-killed or viable tissues was not performed.
- Colour interference with MTT: The test substance did not change the colour, when mixed with deionised water and thus passed the colour interference pre-test. Also its intrinsic colour was not intensive.
DEMONSTRATION OF TECHNICAL PROFICIENCY:
The technical proficiency of the test facility was demonstrated. Appropriate data are provided in 'Any other information on results incl. tables' below.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The mean OD of the tissue replicates treated with the negative control was ≥ 0.8 and ≤ 2.8 for every exposure time (values between 1.689 and 1.783).
- Acceptance criteria met for positive control: The mean viability of the tissue replicates treated with the positive control for 1 h was < 15% compared to the negative control (4.32%).
- Acceptance criteria met for variability between replicate measurements: The standard deviations between the three tissue percentage viability values of each group (test item, positive and negative controls) in the main test were below 18. - Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008.
- Conclusions:
- Under the conditions of the conducted test, the test substance did not possess irritating properties towards reconstructed human epidermis tissue in the EpiDerm™ model.
Reference
Table 1: Details on results |
||||||||||
Treatment Group |
Tissue No. |
OD 570 nm |
Mean OD of 3 Wells |
Mean OD of 3 Wells blank corrected |
Mean OD of 3 tissues |
Rel. Viability [%] Tissue 1, 2 + 3 |
Standard Deviation |
Mean Rel. Viability [%] |
||
Well 1 |
Well 2 |
Well 3 |
||||||||
Blank |
|
0.038 |
0.039 |
0.039 |
0.039 |
|
||||
Negative Control |
1 |
1.734 |
1.713 |
1.736 |
1.727 |
1.689 |
1.751 |
96.469 |
0.054 |
100.0 |
2 |
1.831 |
1.818 |
1.807 |
1.819 |
1.780 |
101.677 |
||||
3 |
1.825 |
1.783 |
1.858 |
1.822 |
1.783 |
101.854 |
||||
Positive Control |
1 |
0.112 |
0.126 |
0.114 |
0.117 |
0.079 |
0.076 |
4.494 |
0.005 |
4.32 |
2 |
0.117 |
0.117 |
0.117 |
0.117 |
0.078 |
4.469 |
||||
3 |
0.108 |
0.109 |
0.109 |
0.109 |
0.070 |
3.989 |
||||
Test Item |
1 |
1.861 |
1.795 |
1.783 |
1.813 |
1.774 |
1.753 |
101.336 |
0.082 |
100.16 |
2 |
1.708 |
1.702 |
1.694 |
1.701 |
1.663 |
94.982 |
||||
3 |
1.838 |
1.886 |
1.864 |
1.862 |
1.824 |
104.175 |
Table 2: Historical control data |
|||
Positive Control; OD at 570 nm after exposure to 5% SDS solution in deionized water (MatTek) |
Negative Control OD at 570 nm DPBS (MatTek) |
||
Tissue Viability [%] |
3.89 |
Mean OD |
1.69 |
Standard Deviation |
1.01 % points |
Standard Deviation |
0.19 |
Range of Viabilities |
2.24 % - 6.19 % |
Range of OD* |
1.28 - 2 |
Mean OD |
0.07 |
* should be 0.8 - 2.8 (OECD 439) or 1.0 - 2.5 (MatTek) |
|
Standard Deviation |
0.02 |
||
Range of OD |
0.03 - 0.11 |
||
Data of 50 sets of controls shared between 195 studies performed from August 2015 until May 2019 (p.p.: percentage points) |
Table 3: Technical proficiency |
||
Proficiency Substance |
Viability [%] |
Category |
Naphtalene acetic acid |
101.7 |
No Cat. |
Isopropanol |
85.5 |
No Cat. |
Methyl stearate |
91.1 |
No Cat. |
Heptyl butyrate |
109.0 |
No Cat. |
Hexyl salicylate |
98.1 |
No Cat. |
Cyclamen aldehyde |
24.1 |
Cat. 2 |
1-Bromohexane |
16.3 |
Cat. 2 |
Potassium hydroxide (5% aq.) |
40.1 |
Cat. 2 |
1-Methyl-3-phenyl-1-piperazine |
21.6 |
Cat. 2 |
Heptanal |
20.6 |
Cat. 2 |
In vitro Skin Irritation Assay: OECD 439 |
||
Proficiency Data (March 2014, non-GLP) performed at ICCR-Roßdorf GmbH Study |
||
Director: Dipl.-Ing. Andreas Heppenheimer |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 Dec 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- adopted in 2017
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants)
- Version / remarks:
- adopted in 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: AB Schlachthof GmbH & Co. KG, 63739 Aschaffenburg, Germany
- Characteristics of donor animals: 14 months old
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions): Hank’s Buffered Salt Solution (HBSS) containing 1% (v/v) penicillin/streptomycin (100 units/mL penicillin and 100 μg/mL streptomycin), cooled in the slaughter-house and during transport.
- Time interval prior to initiating testing: The eyes were transported on the morning of slaughter of the donor animals to the laboratory. The corneae were isolated on the same day after delivery of the eyes.
- indication of any existing defects or lesions in ocular tissue samples: The eyes were carefully examined macroscopically for defects. Only eyes without defects (e.g. vascularization, pigmentation, opacity and scratches) were used in the assay. - Vehicle:
- physiological saline
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 0.75 mL
- Concentration: 20% suspension (w/v) in saline using sonication for 10 min - Duration of treatment / exposure:
- 240 min at 32 ± 1 °C
- Number of animals or in vitro replicates:
- Triplicates for each treatment and control group
- Details on study design:
- SELECTION AND PREPARATION OF CORNEAS
The cornea was carefully removed from the eye using scalpel and rounded scissors. A rim of about 2 mm of tissue (sclera) was left for stability and handling of the isolated cornea. Each cornea was mounted in a specially designed cornea holder.
QUALITY CHECK OF THE ISOLATED CORNEAS
At the end of the equilibration period, the basal opacity was determined (t0). Each cornea with a value of the basal opacity > 7 was discarded.
TREATMENT METHOD: closed chamber
The endothelial side of the cornea was positioned against the O-ring of the posterior part of the holder. The cornea was gently flattened over the O-ring but stretching was avoided. The anterior part of the holder was positioned on top of the cornea and fixed in place with screws. Both compartments of the holder were filled with incubation medium. The posterior compartment was filled first to return the cornea to its natural convex position. Care was taken to assure that no air bubbles were present within the compartments.
REMOVAL OF TEST SUBSTANCE
After exposure, the test substance was rinsed off from the corneae with Eagle’s minimum essential medium (EMEM) containing phenol red for at least three times or more until phenol red was still discoloured (yellow or purple), or the test item was still visible. Since the test item proved difficult to be removed by the rinsing method, the front cover of the holder was opened and the cornea was carefully washed using a gentle stream of incubation medium. Once the medium was free of the test item the corneae were given a final rinse with complete Minimum Essential Medium (cMEM) without phenol red.
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: Corneal opacity was determined by the amount of light transmission through the cornea via an opacitometer (OP_KiT opacitometer (Electro Design, 63-Riom, France)).
- Corneal permeability: Passage of sodium fluorescein dye measured with the aid of a microplate reader (Versamax® Molecular Devices, Software SoftMax Pro Enterprise version 4.7.1) (OD490)
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
DECISION CRITERIA:
Test substance with an IVIS > 55 was regarded as serious eye damage and labelled Category 1 according to CLP/EPS/GHS.
Test substance with an IVIS ≤ 3 was regarded as non-irritant and labelled in no category.
For test substance with an IVIS in the range > 3 ≤ 55 no prediction can be made. - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- 240 min exposure
- Value:
- 2.27
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- DEMONSTRATION OF TECHNICAL PROFICIENCY:
The technical proficiency of the test facility was demonstrated. Appropriate data are provided in 'Any other information on results incl. tables' below.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, the negative control resulted in opacity and permeability values that were less than the established upper limits for background opacity and permeability values for bovine corneae treated with the respective negative control.
- Acceptance criteria met for positive control: yes, the positive control resulted in an IVIS which was within two standard deviations of the current historical mean. - Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008.
- Conclusions:
- Under conditions of the Bovine Corneal Opacity and Permeability Test (BCOP) the test substance was not irritating to the eye. Application of the test substance to bovine corneas resulted in a calculated mean IVIS of 2.27.
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 12 Sept - 10 Oct 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- adopted in 2019
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Species:
- human
- Strain:
- other: EpiOcular™
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount applied: 50 mg (corresponding to 83.3 mg/cm2 of the solid test item)
NEGATIVE CONTROL SUBSTANCE
- Amount(s) applied: 50 µL
POSITIVE CONTROL SUBSTANCE
- Amount(s) applied: 50 µL
- Concentration: ≥ 98% - Duration of treatment / exposure:
- 6 h at 37 ± 1.5 °C and 5 ± 0.5% CO2 in Dulbecco's Minimum Essential Medium (DMEM)
- Duration of post- treatment incubation (in vitro):
- 25 min at RT and approx. 18 h at 37 ± 1.5 °C and 5 ± 0.5% CO2 in DMEM
- Number of animals or in vitro replicates:
- Duplicates for each treatment and control group
- Details on study design:
- - Details of the test procedure used
: The EpiOcular™ Eye Irritation Test (EIT) consists of a topical exposure of the neat test item to a human reconstructed cornea model followed by a cell viability test. Cell viability is measured by dehydrogenase conversion of MTT [(3-4,5-dimethyl thiazole 2-yl) 2,5-diphenyl-tetrazoliumbromide], present in cell mitochondria, into a blue formazan salt that is quantitatively measured after extraction from tissues. The percent reduction of cell viability in comparison of untreated negative controls is used to predict the eye irritation potential.
- RhCE tissue construct used, including batch number : Standard EpiOcular™ Eye Irritation Test (EIT) kit purchased from MatTek Corporation (82105 Bratislava, Slovakia), Lot No.: 30629
- Indication of controls used for direct MTT-reducers and/or colouring test chemicals: The ability of the test substance to directly reduce MTT and to form a blue/purple reaction product was assessed in a pre-experiment. Since the MTT solution colour did not turn blue/purple, the test substance is not presumed to have reduced the MTT. An additional test with freeze-killed tissues did not have to be performed.
- Wavelength used for quantifying MTT formazan: 570 nm
- Description of the method used to quantify MTT formazan : The absorbance (OD570) was measured with a plate reader (Versamax® Molecular Devices, Software Softmax Pro, version 4.7.1).
- Description of evaluation criteria used including the justification for the selection of the cut-off point for the prediction model : The test substance is considered to be not irritating to the eye if the tissue viability after 30 min exposure, 12 min post-exposure immersion and 120 min post-exposure incubation is > 60% relative to the negative control treated tissue.
- Reference to historical data of the RhCE tissue construct : Historical control data are summarised in 'Any other information on results incl. tables' below.
- Demonstration of proficiency in performing the test method before routine use by testing of the proficiency chemicals : The technical proficiency of the test facility was demonstrated and certified by the manufacturer of the test system (MatTek Corporation (Bratislava, Slovakia).
- Acceptable variability between tissue replicates for positive and negative controls : The results are acceptable if the negative control OD is > 0.8 and < 2.5 and if the mean relative viability of the positive control is below 50% of the negative control viability.
- Acceptable variability between tissue replicates for the test chemical: The results are acceptable if the difference of viability between the two relating tissues of a single test item is < 20% in the same run (for positive and negative control tissues and tissues of test items). - Irritation parameter:
- other: % tissue viability
- Run / experiment:
- 6 h exposure
- Value:
- 52.02
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- DEMONSTRATION OF TECHNICAL PROFICIENCY:
The technical proficiency of the test facility was demonstrated and certified by the manufacturer of the test system (MatTek Corporation (Bratislava, Slovakia).
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: The mean OD of the tissue replicates treated with the negative control was ≥ 0.8 and ≤ 2.8 for every exposure time (values between 1.939 and 2.045).
- Acceptance criteria met for positive control: The mean viability of the tissue replicates treated with the positive control was < 50% compared to the negative control (31.07%).
- Acceptance criteria met for variability between replicate measurements: The difference of relative viability between the two relating tissues was < 20%. (values between 0.22% and 10.11%) in the same run (for test item tissues, positive and negative control tissues). - Interpretation of results:
- other: no prediction possible
- Conclusions:
- After treatment with the test substance a mean relative viability value of 52.02% was measured compared to the mean value of the negative control. This value is below the threshold for irritancy of ≤ 60%. Therefore, no prediction of the eye irritation potency can be made for the test substance in this study and under the experimental conditions reported. Furthermore, RhCE test methods show a high percentage of false positive results. In conclusion, additional data are required to conclude on the hazard assessment and classification & labelling of the test substance.
Referenceopen allclose all
Table 1: Details on results
Test Group |
Opacity value = Difference (t240-t0) of Opacity |
Permeability at 490 nm (OD490) |
IVIS |
Mean IVIS |
Standard Deviation in vitro score |
Proposed in vitro Irritancy Score |
|||
|
|
Mean |
|
Mean |
|
|
|
|
|
Negative Control |
0 |
0.00 |
0.067 |
0.062 |
1.01 |
0.94 |
0.06 |
No Category |
|
0 |
0.059 |
0.89 |
|||||||
0 |
0.061 |
0.92 |
|||||||
Positive Control |
95.00* |
0.161* |
97.41 |
106.87 |
8.61 |
Category 1 |
|||
111.00* |
0.217* |
114.25 |
|||||||
107.00* |
0.130* |
108.95 |
|||||||
Test Substance |
1.00* |
0.010* |
1.15 |
2.27 |
0.97 |
No Category |
|||
2.00* |
0.056* |
2.84 |
|||||||
2.00* |
0.055* |
2.82 |
* corrected values
Table 2: Historical control data
|
Positive Control |
Negative Control |
Mean IVIS |
113.39 |
1.29 |
Standard Deviation of IVIS |
12.73 |
0.32 |
Range of IVIS |
87.39 - 146.55 |
0.77 - 2.85 |
95 % Control limits of IVISpos |
87.92-138.85 |
|
Mean Opacity t240min |
110.20 |
0.25 |
Standard Deviation of Opacity t240min |
18.98 |
0.32 |
Range of Opacity t240min |
54.00 - 187.00 |
0.00 - 1.33 |
Mean Permeability |
0.21 |
0.07 |
Standard Deviation of Permeability |
0.29 |
0.01 |
Range of Permeability |
-0.02 - 1.96 |
0.05 - 0.10 |
Values of 83 studies with solid test items sharing 46 sets of controls, performed between January 2016 and July 2019.
Table 1: Details on results
Test Group |
Tissue No. |
Well 1 [OD570] |
Well 2 [OD570] |
Mean [OD570] (Well 1 and well 2) |
Mean [OD570] blank corr. (Well 1 and well2) |
Mean [OD570] of T1 and T2 |
Tissue viabil. [%] |
Viabil. of T1 and T2 [%] |
Diff. of viabil. between T1 and T2 [p.p.] |
|
Blank |
|
0.037 |
0.037 |
0.037 |
|
|||||
Negative Control |
1 |
2.136 |
2.029 |
2.082 |
2.045 |
1.992 |
100.0 |
102.7 |
5.35 |
|
2 |
2.024 |
1.928 |
1.976 |
1.939 |
97.3 |
|||||
Positive Control |
1 |
0.659 |
0.649 |
0.654 |
0.617 |
0.619 |
31.07 |
31.0 |
0.22 |
|
2 |
0.665 |
0.652 |
0.658 |
0.621 |
31.2 |
|||||
Test Item |
1 |
0.986 |
0.960 |
0.973 |
0.936 |
1.036 |
52.02 |
47.0 |
10.11 |
|
2 |
1.183 |
1.165 |
1.174 |
1.137 |
57.1 |
Table 2: Historical control data
Positive Control |
Negative Control [OD570] |
||
Mean Viability |
27.04% |
Mean Absorption |
1.54 |
Standard Deviation |
10.39 p.p. |
Standard Deviation |
0.248 |
Range of Viabilities |
6.73% - 42.54% |
Range of Absorbance |
1.02 – 2.09 |
Mean Absorption |
0.463 |
|
|
Standard Deviation |
0.169 |
||
Range of Absorbance |
0.078 – 0.776 |
Data of 51 studies performed from July 2015 until March 2019.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation / corrosion
The skin irritation potential of esterification product of C16-C18 even numbered, saturated fatty acids and lactic acid, sodium salt (sodium stearoyl lactylate, SSL, CAS No. 25383-99-7, EC No. 246-929-7) was assessed in the in vitro Human Skin Model Test (EpiDerm™) according to OECD guideline 439 under GLP conditions (Muchalla, 2019, EpiDerm). The test item did not prove to be a MTT reducer and it did not change colour when mixed with deionised water or isopropanol. Three tissues of the human skin model EpiDerm™ were treated with the test item, the negative control Dulbecco's Phosphate Buffered Saline (DPBS) and the positive control sodium dodecyl sulphate (5% SDS) for 60 min, respectively. After treatment with the negative control the absorbance values were well within the required range of the acceptability criterion thus assuring the quality of the tissues. Treatment with the positive control induced a sufficient decrease in the relative absorbance as compared to the negative control thus assuring the validity of the test system. After treatment with the test item, the mean relative viability value was 100.16% compared to the relative absorbance value of the negative control. This value is above the threshold for irritancy of ≤ 50%. Therefore, the test item is not considered to possess an irritant potential.
Eye irritation / serious eye damage
An in vitro study was performed to assess the eye irritation potential of SSL by means of the Human Cornea Model Test (EpiOcular) according to OECD guideline 492 under GLP conditions (Sokolowski, 2019, EpiOcular). The test item did not reduce MTT and its intrinsic color was not intensive and the optical density (OD) of the test item in deionised water or isopropanol at 570 nm after blank correction was < 0.08. Each 50 mg of the test item or 50 μL of the negative control (deionised water) and of the positive control (methyl acetate), were applied to each duplicate tissue for 6 h. The mean OD of the tissue replicates treated with the negative control was > 0.8 and < 2.5, thus showing the quality of the tissues. Treatment with the positive control induced a decrease below 50% viability compared with the negative control value in the relative absorbance, thus ensuring the validity of the test system. All other quality and validity criteria were also met. After treatment with the test item a mean relative viability value of 52.02% was measured compared to the mean value of the negative control. This value is below the threshold for irritancy of ≤ 60%. Therefore, no prediction of the eye irritation potency can be made for the test substance in this study and under the experimental conditions reported. Furthermore, test methods based on reconstructed human epithelium (RhCE) show a high percentage of false positive results. In conclusion, additional data are required to conclude on the hazard assessment and classification and labelling of the test substance.
A second in vitro study was performed to assess the corneal irritation and damage potential of SSL using the Bovine Corneal Opacity and Permeability test method (BCOP) according to OECD guideline 437 and observing GLP conditions (Sokolowski, 2020, BCOP). After a first opacity measurement of the fresh bovine corneae, the 20% (w/v) suspension in saline of the test item as well as the positive and the negative controls were each applied to different corneae and incubated for 240 min at 32 ± 1 °C. After the incubation phase the test item, the positive controls (10% (w/v) benzalkonium chloride in saline) and the negative controls (physiological saline) were each rinsed from the corneae and opacity was measured again. After the opacity measurements, permeability of the corneae was determined by measuring spectrophotometrically the transfer of sodium fluorescein after incubation for 90 min at 32 ± 1 °C. With the negative control, neither an increase of opacity nor permeability of the corneae was observed. The positive control showed clear opacity and distinctive permeability of the corneae. Relative to the negative control, the test item did not cause a relevant increase of the corneal opacity or permeability. The calculated mean in vitro irritancy score (IVIS) was 2.27. According to OECD guideline 437 the test item does not need to be classified for eye irritation or serious eye damage.
Justification for classification or non-classification
The available data on skin and eye irritation of esterification product of C16-C18 even numbered, saturated fatty acids and lactic acid, sodium salt (sodium stearoyl lactylate, SSL, CAS No. 25383-99-7, EC No. 246-929-7) do not meet the criteria for classification according to Regulation (EC) No. 1272/2008 (CLP) and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.